Cocrystal Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $13.50 Millions, with shareholders equity totaling $4.12 Millions.
The company employs approximately 11 people and operates in the Health sector, within the Pharmaceutical Products industry.
Over the past 12 months, Cocrystal Pharma Inc. reported $220.00 Thousand in revenue, generating net income of $-8.84 Millions.
Key financial metrics include a P/E ratio of -1.53, a price-to-book (P/B) ratio of 3.28, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker COCP.